 | Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) Stock Price Up 8.3%
americanbankingnews.com - January 25 at 7:32 PM |
| Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) Trading 9.7% Higher
americanbankingnews.com - January 12 at 7:36 PM |
 | Navidea Biopharmaceuticals to Present at the 2021 ICR Conference On January 14, 2021
finance.yahoo.com - January 7 at 8:10 AM |
| Navidea Biopharmaceuticals to Present at the 2021 ICR Conference On January 14, 2021
finance.yahoo.com - January 7 at 8:10 AM |
| Head-To-Head Comparison: Navidea Biopharmaceuticals (NYSE:NAVB) & OncoCyte (NYSE:OCX)
americanbankingnews.com - January 1 at 3:10 AM |
| Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) Shares Up 7.5%
americanbankingnews.com - December 31 at 6:54 PM |
| Navidea Biopharmaceuticals, Inc. (NYSEAMERICAN:NAVB) Director Malcolm G. Witter Acquires 5,000 Shares
americanbankingnews.com - December 31 at 4:27 AM |
| Navidea Biopharmaceuticals Strengthens Board of Directors with the Appointment of Malcolm Witter
finance.yahoo.com - December 28 at 7:35 AM |
| New Strong Sell Stocks for December 8th
finance.yahoo.com - December 8 at 12:00 PM |
 | Navidea Biopharmaceuticals
fool.com - December 6 at 10:10 PM |
|
| Is Navidea Biopharmaceuticals Inc (NAVB) A Good Stock To Buy?
finance.yahoo.com - November 26 at 9:09 PM |
 | AZN's Repurposed COVID-19 Drug Fails, NAVB On Watch, CVAC Rallies On Storage Advantage Of CVnCoV
nasdaq.com - November 13 at 6:16 AM |
 | Navidea Biopharmaceuticals, Inc. (NAVB) CEO Jed Latkin on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 13 at 1:28 AM |
| Navidea imaging agent shows predictive value in rheumatoid arthritis
seekingalpha.com - November 12 at 6:02 PM |
| Navidea Biopharmaceuticals Announces Positive Results Encompassing Additional Patients From Its Ongoing Phase 2B Study in Rheumatoid Arthritis
finance.yahoo.com - November 12 at 6:02 PM |
| Navidea Biopharmaceuticals Reports Third Quarter and Year-to-Date 2020 Financial Results
finance.yahoo.com - November 12 at 6:02 PM |
| Navidea Biopharmaceuticals to Host Third Quarter 2020 Earnings Conference Call and Corporate Update
finance.yahoo.com - November 5 at 6:53 PM |
| Navidea Biopharma (NAVB) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
finance.yahoo.com - October 29 at 2:13 PM |
| Navidea Biopharmaceuticals to Present at the Virtual Investor KOL Roundtable
finance.yahoo.com - October 22 at 7:35 AM |
| Navidea Biopharma's lead asset data to be presented in an upcoming Rheumatology meet
seekingalpha.com - October 9 at 12:43 PM |
 | Navidea to ring opening bell at NYSE
bizjournals.com - September 28 at 6:18 PM |
| Navidea Biopharmaceuticals: Too Many Risks Involved
seekingalpha.com - September 14 at 5:49 PM |
| Navidea Biopharmaceuticals Wins Dismissal of Platinum Loan Litigation
finance.yahoo.com - September 2 at 5:39 PM |
| Breakeven On The Horizon For Navidea Biopharmaceuticals, Inc. (NYSEMKT:NAVB)
finance.yahoo.com - August 24 at 5:45 PM |
| Navidea Biopharmaceuticals to Present at The LD 500 Virtual Investor Conference
finance.yahoo.com - August 24 at 5:45 PM |
| Navidea Biopharmaceuticals, Inc. (NAVB) CEO Jed Latkin on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 14 at 11:51 PM |
| Navidea Biopharmaceuticals Reports Second Quarter and Year-to-Date 2020 Financial Results
finance.yahoo.com - August 13 at 5:53 PM |
| Jubilant Radiopharma and Navidea Biopharmaceuticals Sign Binding Memorandum of Understanding for Commercialization Partnership
finance.yahoo.com - August 10 at 9:27 AM |
| Navidea Biopharma secures $25M of committed equity financing
seekingalpha.com - August 10 at 9:07 AM |
| Navidea Biopharmaceuticals Signs Binding Framework for Commercialization Partnership with Jubilant Radiopharma
finance.yahoo.com - August 10 at 9:07 AM |
|
| Navidea Biopharmaceuticals to Host Second Quarter 2020 Earnings Conference Call and Corporate Update
finance.yahoo.com - August 6 at 5:24 PM |
| INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Navidea Biopharmaceuticals, Inc. for Potential Breach of Fiduciary Duty Claims
finance.yahoo.com - August 5 at 7:51 AM |
| Is the Options Market Predicting a Spike in Navidea Biopharmaceuticals (NAVB) Stock?
finance.yahoo.com - June 17 at 12:54 PM |
| Navidea Biopharmaceuticals Announces Full Enrollment in its Ongoing Phase 2B Trial of Tc99m Tilmanocept in Rheumatoid Arthritis (RA)
finance.yahoo.com - June 15 at 9:49 AM |
| Navidea Biopharmaceuticals to Present at the Virtual Investor Fireside Chat Series
finance.yahoo.com - June 9 at 8:56 AM |
| Navidea Biopharmaceuticals Announces Acceptance of Abstract for Presentation at the European League Against Rheumatism (EULAR) Congress
finance.yahoo.com - June 3 at 8:38 AM |
 | Why This Rheumatoid Arthritis Study Is Huge for Navidea Biopharma
247wallst.com - May 22 at 2:56 PM |
| Navidea Bio up big on positive Tc99m tilmanocept data in rheumatoid arthritis
seekingalpha.com - May 22 at 9:43 AM |
 | Thinking about buying stock in Navidea Biopharmaceuticals, Aurora Cannabis, Under Armour, Onconova Therapeutics, or BJs Wholesale Club?
www.prnewswire.com - May 22 at 9:43 AM |
| Navidea Biopharmaceuticals stock rockets toward 13-month high on heavy volume after update trial data
finance.yahoo.com - May 22 at 9:43 AM |
| Navidea Biopharmaceuticals Announces Positive Results of Second Interim Analysis of Ongoing Phase 2B Study in Rheumatoid Arthritis
finance.yahoo.com - May 21 at 6:04 PM |
| Edited Transcript of NAVB earnings conference call or presentation 14-May-20 9:00pm GMT
finance.yahoo.com - May 15 at 8:00 AM |
| Navidea Biopharmaceuticals Reports First Quarter 2020 Financial Results
finance.yahoo.com - May 14 at 7:36 PM |
| Navidea regains European rights to Lymphoseek
seekingalpha.com - May 11 at 5:47 PM |
| Navidea Biopharmaceuticals to Host First Quarter 2020 Earnings Conference Call and Corporate Update
finance.yahoo.com - May 7 at 7:26 AM |
 | Navidea Biopharmaceuticals Appoints Dr. Kathy Rouan to Board of Directors
www.bloomberg.com - May 4 at 5:29 PM |
| Navidea stays on development track amid pandemic; shares up 4%
seekingalpha.com - April 22 at 2:29 PM |
| Navidea Biopharmaceuticals Provides Statement Regarding COVID-19 Pandemic
finance.yahoo.com - April 22 at 9:04 AM |
| What You Must Know About Navidea Biopharmaceuticals, Inc.'s (NYSEMKT:NAVB) Beta Value
finance.yahoo.com - April 21 at 1:02 PM |
| What You Must Know About Navidea Biopharmaceuticals, Inc.'s (NYSEMKT:NAVB) Beta Value
finance.yahoo.com - April 21 at 1:02 PM |
